Odonate Therapeutics, Inc. Operating Lease Right-of-Use Assets
Odonate Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $3.59 million as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2021-11-10
- 2021-09-30: Operating Lease, Right-of-Use Asset $3.59M.
- 2021-06-30: Operating Lease, Right-of-Use Asset $3.73M.
- 2021-03-31: Operating Lease, Right-of-Use Asset $3.88M.
- 2020-12-31: Operating Lease, Right-of-Use Asset $4.02M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2021-09-30 | $3.59M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $3.73M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $3.88M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $4.02M 10-Q · filed 2021-11-10 |
| 2020-09-30 | $4.16M 10-Q · filed 2020-10-28 |
| 2020-06-30 | $1.47M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $1.53M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $1.58M 10-K · filed 2021-02-23 |
| 2019-09-30 | $1.76M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.91M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $2.07M 10-Q · filed 2019-04-25 |
| 2019-01-01 | $2.20M 10-K · filed 2020-02-20 |